165 related articles for article (PubMed ID: 33709550)
1. Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer.
Morimoto H; Hida Y; Maishi N; Nishihara H; Hatanaka Y; Li C; Matsuno Y; Nakamura T; Hirano S; Hida K
Thorac Cancer; 2021 May; 12(9):1347-1357. PubMed ID: 33709550
[TBL] [Abstract][Full Text] [Related]
2. High expression of biglycan is associated with poor prognosis in patients with esophageal squamous cell carcinoma.
Zhu YH; Yang F; Zhang SS; Zeng TT; Xie X; Guan XY
Int J Clin Exp Pathol; 2013; 6(11):2497-505. PubMed ID: 24228112
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single-cell transcriptomic study.
Zheng S; Liang JY; Tang Y; Xie J; Zou Y; Yang A; Shao N; Kuang X; Ji F; Liu X; Tian W; Xiao W; Lin Y
Clin Transl Med; 2023 Feb; 13(2):e1189. PubMed ID: 36772945
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer.
Jacobsen F; Kraft J; Schroeder C; Hube-Magg C; Kluth M; Lang DS; Simon R; Sauter G; Izbicki JR; Clauditz TS; Luebke AM; Hinsch A; Wilczak W; Wittmer C; Büscheck F; Höflmayer D; Minner S; Tsourlakis MC; Huland H; Graefen M; Budäus L; Thederan I; Salomon G; Schlomm T; Melling N
Neoplasia; 2017 Sep; 19(9):707-715. PubMed ID: 28830008
[TBL] [Abstract][Full Text] [Related]
5. Recombinant biglycan promotes bone morphogenetic protein-induced osteogenesis.
Miguez PA; Terajima M; Nagaoka H; Ferreira JA; Braswell K; Ko CC; Yamauchi M
J Dent Res; 2014 Apr; 93(4):406-11. PubMed ID: 24482033
[TBL] [Abstract][Full Text] [Related]
6. Biglycan as a potential diagnostic and prognostic biomarker in multiple human cancers.
Zhao SF; Yin XJ; Zhao WJ; Liu LC; Wang ZP
Oncol Lett; 2020 Mar; 19(3):1673-1682. PubMed ID: 32194659
[TBL] [Abstract][Full Text] [Related]
7. Biglycan potentially regulates angiogenesis during fracture repair by altering expression and function of endostatin.
Myren M; Kirby DJ; Noonan ML; Maeda A; Owens RT; Ricard-Blum S; Kram V; Kilts TM; Young MF
Matrix Biol; 2016; 52-54():141-150. PubMed ID: 27072616
[TBL] [Abstract][Full Text] [Related]
8. Biglycan deficiency interferes with ovariectomy-induced bone loss.
Nielsen KL; Allen MR; Bloomfield SA; Andersen TL; Chen XD; Poulsen HS; Young MF; Heegaard AM
J Bone Miner Res; 2003 Dec; 18(12):2152-8. PubMed ID: 14672350
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer.
Schulz GB; Grimm T; Sers C; Riemer P; Elmasry M; Kirchner T; Stief CG; Karl A; Horst D
Urol Oncol; 2019 Aug; 37(8):530.e9-530.e18. PubMed ID: 31176613
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy.
Cong L; Maishi N; Annan DA; Young MF; Morimoto H; Morimoto M; Nam JM; Hida Y; Hida K
Breast Cancer Res; 2021 May; 23(1):51. PubMed ID: 33966638
[TBL] [Abstract][Full Text] [Related]
11. Expression of Biglycan in First Trimester Chorionic Villous Sampling Placental Samples and Altered Function in Telomerase-Immortalized Microvascular Endothelial Cells.
Chui A; Gunatillake T; Brennecke SP; Ignjatovic V; Monagle PT; Whitelock JM; van Zanten DE; Eijsink J; Wang Y; Deane J; Borg AJ; Stevenson J; Erwich JJ; Said JM; Murthi P
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1168-1179. PubMed ID: 28408374
[TBL] [Abstract][Full Text] [Related]
12. Serum Biglycan as a Diagnostic Marker for Non-Alcoholic Steatohepatitis and Liver Fibrosis.
Cengiz M; Yilmaz G; Ozenirler S
Clin Lab; 2021 Mar; 67(3):. PubMed ID: 33739030
[TBL] [Abstract][Full Text] [Related]
13. Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells.
Yamamoto K; Ohga N; Hida Y; Maishi N; Kawamoto T; Kitayama K; Akiyama K; Osawa T; Kondoh M; Matsuda K; Onodera Y; Fujie M; Kaga K; Hirano S; Shinohara N; Shindoh M; Hida K
Br J Cancer; 2012 Mar; 106(6):1214-23. PubMed ID: 22374465
[TBL] [Abstract][Full Text] [Related]
14. Biglycan modulates angiogenesis and bone formation during fracture healing.
Berendsen AD; Pinnow EL; Maeda A; Brown AC; McCartney-Francis N; Kram V; Owens RT; Robey PG; Holmbeck K; de Castro LF; Kilts TM; Young MF
Matrix Biol; 2014 Apr; 35():223-31. PubMed ID: 24373744
[TBL] [Abstract][Full Text] [Related]
15. Effects of the angiotensin II receptor blocker losartan on the monocyte expression of biglycan in hypertensive patients.
Sardo MA; Mandraffino G; Riggio S; D'Ascola A; Alibrandi A; Saitta C; Imbalzano E; Castaldo M; Cinquegrani M; Saitta A
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):933-8. PubMed ID: 20497421
[TBL] [Abstract][Full Text] [Related]
16. Expression and the Prognostic Value of Biglycan in Gastric Cancer.
Hu S; Li P; Wang C; Liu X
Comput Math Methods Med; 2022; 2022():2656480. PubMed ID: 36110576
[TBL] [Abstract][Full Text] [Related]
17. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells.
Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H
J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283
[TBL] [Abstract][Full Text] [Related]
18. Biglycan enhances the ability of migration and invasion in endometrial cancer.
Sun H; Wang X; Zhang Y; Che X; Liu Z; Zhang L; Qiu C; Lv Q; Jiang J
Arch Gynecol Obstet; 2016 Feb; 293(2):429-38. PubMed ID: 26275380
[TBL] [Abstract][Full Text] [Related]
19. Biglycan neo-epitope (BGN
Adepu S; Ekman S; Leth J; Johansson U; Lindahl A; Skiöldebrand E
Osteoarthritis Cartilage; 2022 Oct; 30(10):1328-1336. PubMed ID: 35870736
[TBL] [Abstract][Full Text] [Related]
20. The Extracellular Small Leucine-Rich Proteoglycan Biglycan Is a Key Player in Gastric Cancer Aggressiveness.
Pinto F; Santos-Ferreira L; Pinto MT; Gomes C; Reis CA
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]